About Us

Book a consultation

meet your triple board-certified obesity medicine specialist

doctor tran le, MD, DABOM, is a board-certified obesity medicine physician with additional board certifications in addiction medicine and occupational medicine. she has completed fellowship training in addiction medicine where she gained expertise in treating disorders with complex interactions among neurobiology, genetics, the environment, and an individual’s life experiences, similar to that of the disease of obesity. this unique training background allows her to treat the disease of obesity in a non-judgmental, patient-centered approach.

as a native texan, doctor le is proud to provide individualized weight loss care accessible to texans of all ages and body types throughout the state.

doctor tran le

education

fellowship: university of utah addiction medicine
residency: university of utah occupational and environmental medicine
doctor of medicine (MD): mcgovern medical school at uthealth houston
bachelor of science: southwestern university in georgetown, texas

certifications

board certification in obesity medicine: american board of obesity medicine
board certification in occupational and environmental medicine: american board of preventive medicine
board certification in addiction medicine: american board of preventive medicine
licensure: full physician license in texas and utah (NPI: 1194212258)

society memberships

Obesity Medicine Association
American Medical Association
American Society of Addiction Medicine

languages

english
vietnamese

our mission

here at texas obesity medicine, we want you to know that you no longer have to live a life filled with anxiety about missed workouts, food-noise, or the shame associated with yo-yo dieting. now you can reach your weight goals, all the while living freely with peace of mind thanks to evidenced-based obesity treatment options. newer, more effective combination medications are entering clinical trials each year, and texas obesity medicine will ensure that you are able to take advantage of the latest breakthroughs in medical science at affordable prices. we are a weight loss home that cares about you!

our HIPAA privacy policy

click here to get started today!

phone: 713-568-9102

fax: 713-900-2943

email: texasobesitymedicine@gmail.com

address: 5373 w alabama st #204 houston, tx 77056

*Compounded medications are not, and must not be confused with, brand name, FDA-approved medications. Texas Obesity Medicine, PLLC ("Texas Obesity Medicine") provides access to compounded medications, if medically necessary, as determined by a licensed prescriber. Texas Obesity Medicine is not a pharmacy and is not regulated under Sections 503A or 503B of the federal Food Drug and Cosmetics Act. Texas Obesity Medicine is a medical practice regulated under the laws, rules, and regulations of the state of Texas and the Texas Medical Board and only provides services to patients in the state of Texas. Texas Obesity Medicine prescribes medications as determined by a licensed provider following a review of medical history and patient presentation in an appropriate patient-provider encounter, whether virtual or in-person. Prescribers at Texas Obesity Medicine may, but are not required to or guaranteed to, prescribe compounded medications, if medically indicated. Compounded medications are not FDA-approved and there is a possibility that they may differ in risks, benefits, and side-effects from FDA-approved products. Individual results and experiences may vary. Novo Nordisk Inc. and Eli Lilly and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus©, Ozempic©, Wegovy©) and tirzepatide (Zepbound©, Mounjaro©), respectively. These manufacturers do not sell these medications for compounding purposes. The Food and Drug Administration ("FDA") has stated that "[c]ompounded drugs . . . do not have the same safety, quality, and effectiveness assurances as approved drugs" and "[u]nnecessary use of compounded drugs unnecessarily exposes patients to potentially serious health risks." Only FDA-approved medications have been found to be safe and effective by the FDA. The FDA has stated that "[t]he safety and effectiveness of combining semaglutide with other ingredients," including B-vitamins, "has not been established." The safety and effectiveness of combining tirzepatide with other ingredients has likewise not been established by the FDA. GLP-1 medications compounded with B-vitamins do not offer any established enhanced weight loss benefits, and can only be prescribed by order of a licensed prescriber when medically indicated. Payment of a membership fee does not guarantee prescription of any medication, and your prescriber will determine what medication(s), including name brand, generic, and/or compounded medications, are indicated for your condition(s). If compounded medications are medically indicated as determined by a properly licensed prescriber, prescriptions will be sent to an appropriate facility in the state of Texas for fulfillment.

The information provided on this website is not a substitute for professional medical advice, diagnosis, or treatment and is provided for informational purposes only. If you have any concerns or questions about your health or any medical issue, please consult a physician or other appropriate, licensed medical professional. This website is an advertisement for professional services and not any specific medication. All listed prices are for illustrative purposes only and do not represent guarantees or commitments on the part of Texas Obesity Medicine or its providers that any medication is available or that said medication can be purchased at the listed prices, presently or in the future.

By accessing this website, you agree to accept the above statements and will not file or in any other way commence any civil action, complaint, petition, or other lawsuit regarding the above statements and disclaim any and all damages or claims for relief, in law or equity, as a result thereof.

Copyright Texas Obesity Medicine, PLLC, 2025. All rights reserved.

Share by: